GRN1005 Alone or With Herceptin for Breast Cancer With Brain Metastases
by on Monday, March 19th, 2012 | No Comments
Conditions: Breast Cancer; Breast Tumors; Breast Neoplasms
Interventions: Drug: Trastuzumab; Drug: GRN1005; Drug: 3′-deoxy-3 18F-Flurorothymidine
Sponsor: National Cancer Institute (NCI)
Recruiting – verified February 2012
View post: GRN1005 Alone or With Herceptin for Breast Cancer With Brain Metastases